[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100586850":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":10,"centralContacts":22,"locations":28,"responsibleParty":44,"collaborators":10,"id":46,"slug":10,"hasResults":47,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":24,"eligibilityCriteria":51,"healthyVolunteers":47,"sex":52,"minAge":53,"maxAge":10,"enrollmentInfo":54,"targetDuration":10,"studyType":57,"phases":10,"briefSummary":58,"conditions":59,"keywords":61,"overallStatus":31,"whyStopped":10,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":74},{"fullName":5,"class":6},"Abbott Medical Devices","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Treatment Group",null,"Patients with symptomatic, severe or greater TR who received a T-TEER with the TriClip system",[13],"Device: The TriClip System",{"label":15,"type":10,"description":16,"interventionNames":10},"Control Group","Patients with symptomatic, severe or greater TR without T-TEER",[18],{"type":19,"name":20,"description":20,"armGroupLabels":21,"otherNames":10},"DEVICE","The TriClip System",[9],[23],{"name":24,"role":25,"phone":26,"phoneExt":10,"email":27},"TRICARE","CONTACT","(408) 845-3000","TRICARE@abbott.com",[29],{"facility":30,"status":31,"city":32,"state":33,"zip":34,"country":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"Abbott","RECRUITING","Santa Clara","California","95054","United States",{"type":37,"coordinates":38},"Point",[39,40],-121.95524,37.35411,{"lat":40,"lon":39},[43],{"name":24,"role":25,"phone":26,"phoneExt":10,"email":27},{"type":45,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100586850",false,"NCT06920745","TriClip CED RWE Study","TRIClip CoverAge With Evidence Development (CED) Real-World Evidence (RWE) Study (TRICARE)","Inclusion Criteria:\n\n* Patients ≥ 18 years of age at time of implant\n* Patients with symptomatic, severe or greater Tricuspid Regurgitation who have received the TriClip system (treatment group) or have not undergone T-TEER (control group)\n\nExclusion Criteria:\n\n* Patients with less than severe Tricuspid Regurgitation\n* Patients with a prior history of surgical or transcatheter tricuspid valve replacement\n* Patients with a surgical or transcatheter aortic or mitral valve intervention within 90 days prior to index","ALL","18 Years",{"count":55,"type":56},2200,"ESTIMATED","OBSERVATIONAL","This Coverage with Evidence Development (CED) study evaluates the long-term health outcomes of patients with symptomatic, severe or greater Tricuspid Regurgitation who received a Tricuspid Transcatheter Edge-to-Edge Repair (T-TEER) procedure using the TriClip system.",[60],"Tricuspid Regurgitation",[62,63,64],"TriClip","Coverage with Evidence Development","Tricuspid Transcatheter Edge-to-Edge Repair","2025-08-06",{"date":67,"type":68},"2025-08-11","ACTUAL",{"date":70,"type":68},"2025-07-08",{"date":72,"type":56},"2032-07",{"name":5,"class":6},1]